{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:32:29Z","timestamp":1781530349026,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There are very limited reports on anti-metabolic glutamate receptor5 (mGluR5) encephalitis, especially lacking of pediatric research. The disease was mostly accompanied by tumors, mainly Hodgkin's lymphoma. No reports of other tumors, such as gangliocytoma have been reported to associate with anti-mGluR5 encephalitis so far.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation and literature reviews<\/jats:title>\n                <jats:p>We reported a case of a 12-year-old boy with anti-mGluR5 encephalitis complicated with gangliocytoma. The patient suffered from mental disorders including auditory hallucination, and sleep disorders. His cranial magnetic resonance imaging (MRI) showed an abnormality in the right insular lobe. Autoimmune encephalitis antibodies testing was positive for mGluR5 IgG antibody both in cerebrospinal fluid and serum (1:3.2, 1:100 respectively). Abdominal CT indicated a mass in left retroperitoneal confirmed with gangliocytoma via pathology. The patient underwent resection of gangliocytoma. After first-line immunotherapy (glucocorticoid, gamma globulin), his condition was improved. Furthermore, we provide a summary of 6 pediatric cases of Anti-mGluR5 encephalitis. Most of them complicated with Hodgkin's lymphoma, except the case currently reported comorbid with gangliocytoma. The curative effect is satisfactory.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We report the first patient with anti-mGlur5 encephalitis complicated with gangliocytoma. It suggests that in addition to paying attention to the common lymphoma associated with anti-mGlur5 encephalitis, we should also screen the possibility of other tumors for early detection of the cause, active treatment and prevention of recurrence.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-024-03528-z","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T08:02:27Z","timestamp":1705132947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Anti-metabolic glutamate receptor 5 encephalitis with gangliocytoma: a case and review of the literature"],"prefix":"10.1186","volume":"24","author":[{"given":"Kaili","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,13]]},"reference":[{"key":"3528_CR1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S0140-6736(82)91887-6","volume":"10","author":"I Carr","year":"1982","unstructured":"Carr I. The Ophelia syndrome:memory loss in Hodgkin\u2019s disease. Lancet. 1982;10:844\u20135.","journal-title":"Lancet"},{"key":"3528_CR2","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","volume":"77","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, Martinez-Hernandez E, Titulaer MJ, et al. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology. 2011;77:1698\u2013701.","journal-title":"Neurology"},{"key":"3528_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/978-1-4939-9077-1_15","volume":"1941","author":"WJ Scotton","year":"2019","unstructured":"Scotton WJ, Karim A, Jacob S, et al. Receptor Antibodies in Autoimmune Central Nervous System Disease: Basic Mechanisms, Clinical Features, and Antibody Detection. Methods Mol Biol. 2019;1941:225\u201355.","journal-title":"Methods Mol Biol"},{"key":"3528_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/B978-0-444-63432-0.00012-8","volume":"133","author":"MA De Bruijn","year":"2016","unstructured":"De Bruijn MA, Titulaer MJ. Anti-NMDAR encephalitis and other glutamate and GABA receptor antibody encephalopathies. Handb Clin Neurol. 2016;133:199\u2013217.","journal-title":"Handb Clin Neurol"},{"key":"3528_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","volume":"50","author":"CM Niswender","year":"2010","unstructured":"Niswender CM, Conn PJ. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol. 2010;50:295\u2013322.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3528_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1258\/acb.2011.011140","volume":"49","author":"AR Karim","year":"2012","unstructured":"Karim AR, Jacob S. Immunological markers in neurological disorders. Ann Clin Biochem. 2012;49:29\u201343.","journal-title":"Ann Clin Biochem"},{"key":"3528_CR7","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1212\/WNL.0000000000005614","volume":"90","author":"M Spatola","year":"2018","unstructured":"Spatola M, Sabater L, Planagum\u00e0 J, et al. Encephalitis with mGluR5 antibodies: symptoms and antibody effects. Neurology. 2018;90:1964\u201372.","journal-title":"Neurology"},{"key":"3528_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.mcn.2018.05.002","volume":"91","author":"N Scheefhals","year":"2018","unstructured":"Scheefhals N, MacGillavry HD. Functional organization of postsynaptic glutamate receptors. Mol Cell Neurosci. 2018;91:82\u201394.","journal-title":"Mol Cell Neurosci"},{"key":"3528_CR9","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1212\/WNL.0000000000000865","volume":"83","author":"H Pr\u00fcss","year":"2014","unstructured":"Pr\u00fcss H, Rothkirch M, Kopp U, et al. Limbic encephalitis with mGluR5 antibodies and immunotherapy-responsive prosopagnosia. Neurology. 2014;83:1384\u20136.","journal-title":"Neurology"},{"key":"3528_CR10","first-page":"131","volume":"54","author":"YQ Chen","year":"2021","unstructured":"Chen YQ, Gu H, Xu G, et al. An electroencephalogram manifested as a delta brush of antimetabolic glutamate receptor 5 encephalitis in one case. Chin J Neurol. 2021;54:131\u20135.","journal-title":"Chin J Neurol"},{"key":"3528_CR11","first-page":"44","volume":"47","author":"KD Guo","year":"2021","unstructured":"Guo KD, Lin J, Hong Z. Anti-mglur5 encephalitis: a case report. Chin J Nerv ment Dis. 2021;47:44\u20137.","journal-title":"Chin J Nerv ment Dis"},{"key":"3528_CR12","unstructured":"Huang QM,Tang YL. Autoimmune encephalitis with mGluR5 antibody overlap: a case report. Chin Med Case Repository. 2022;04(01):E02924."},{"key":"3528_CR13","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.3389\/fimmu.2018.02568","volume":"5","author":"C Guevara","year":"2018","unstructured":"Guevara C, Farias G, Silva-Rosas C, et al. Encephalitis Associated to Metabotropic Glutamate Receptor 5 (mGluR5) Antibodies in Cerebrospinal Fluid. Front Immunol. 2018;5:2568.","journal-title":"Front Immunol"},{"issue":"13","key":"3528_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.919125","volume":"5","author":"J Fu","year":"2022","unstructured":"Fu J, Peng L, Yang Y, et al. Case report: Overlapping syndrome mimicking infectious meningoencephalitis in a patient with coexistent MOG, NMDAR, mGluR5 antibody positivity. Front Immunol. 2022;5(13): 919125.","journal-title":"Front Immunol"},{"key":"3528_CR15","doi-asserted-by":"publisher","first-page":"e31063","DOI":"10.1097\/MD.0000000000031063","volume":"43","author":"T Huo","year":"2022","unstructured":"Huo T, Zhao J, Wang T, et al. A Chinese female patient with LGI1 and mGluR5 antibodies: A case report. Medicine (Baltimore). 2022;43:e31063.","journal-title":"Medicine (Baltimore)."},{"key":"3528_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.seizure.2022.10.021","volume":"103","author":"Y Jia","year":"2022","unstructured":"Jia Y, Guo B, Li J, et al. Focal motor seizure as a presenting symptom in anti-mGluR5 encephalitis: A case report. Seizure. 2022;103:82\u20135.","journal-title":"Seizure"},{"key":"3528_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.808131","volume":"13","author":"W Yan","year":"2022","unstructured":"Yan W, Zhao C, Zhang H, et al. Case Report: Guillain-Barr\u00e9 Syndrome Characterized by Severe Headache Associated With Metabotropic Glutamate Receptor 5 Antibody. Front Immunol. 2022;13: 808131.","journal-title":"Front Immunol"},{"key":"3528_CR18","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/ana.25216","volume":"83","author":"SH Mueller","year":"2018","unstructured":"Mueller SH, F\u00e4rber A, Pr\u00fcss H, et al. Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis. Ann Neurol. 2018;83:863\u20139.","journal-title":"Ann Neurol"},{"key":"3528_CR19","doi-asserted-by":"crossref","unstructured":"Guo K, Liu X, Gong X, et al. Autoimmune encephalitis with mGluR5 antibodies: A case series from China and review of the literature. Front Immunol. 2023;14:1146536.","DOI":"10.3389\/fimmu.2023.1146536"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03528-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-024-03528-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03528-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T08:03:43Z","timestamp":1705133023000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-024-03528-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,13]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3528"],"URL":"https:\/\/doi.org\/10.1186\/s12883-024-03528-z","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,13]]},"assertion":[{"value":"4 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Committee of Guangzhou Women and Children\u2019s Medical Center and conducted ethically in accordance with the World Medical Association Declaration of Helsinki. Written informed consent was obtained from his parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent regarding the submission and potential publication of this manuscript was obtained from his parents. Additionally, consent for treatment was likewise obtained in the usual fashion during the course of the patient\u2019s hospitalization.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}